avita medical sec

of avita medical limited . ... AVITA MEDICAL SEC FILINGS. All Rights Reserved. AVITA Medical’s proprietary technology has evidence for additional skin applications beyond treating burns, such as chronic and traumatic wounds, scar revision, and vitiligo. AVITA Medical’s proprietary technology has evidence for additional skin applications beyond treating burns, such as chronic and traumatic wounds, scar revision, and vitiligo. constitution . The principal listing of our ordinary shares and to purchase our ordinary shares is the Australian Securities Exchange, or ASX. INVESTOR RESOURCES. Latest News. corporations act . SEC Filing Details AVITA Medical is a publicly listed, global regenerative medicine company that provides a novel approach to skin regeneration. INVESTOR RESOURCES. Report of unscheduled material events or corporate eventStatement of changes in beneficial ownership of securitiesTermination of registration under Section 12(g) or suspension of duty to file reportsReport of unscheduled material events or corporate eventInitial filing by director officer or owner of more than ten percent.Initial filing by director officer or owner of more than ten percent.Initial filing by director officer or owner of more than ten percent.Initial filing by director officer or owner of more than ten percent.Initial filing by director officer or owner of more than ten percent.Initial filing by director officer or owner of more than ten percent.AVITA Medical is a publicly listed, global regenerative medicine company that provides a novel approach to skin regeneration. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to AVITA, its subsidiaries or affiliates. No use of any AVITA trademark, trade name, or trade dress in this site may be made without the prior written authorization of AVITA, except to identify the product or services of the company.Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to AVITA, its subsidiaries or affiliates. This page shows recent SEC filings related to Avita Medical Ltd. 2019-09-19: EX-2.1: AVMXF / Avita Medical Ltd. EX-2.1 - - EX-2.1 EX-2.1 Exhibit 2.1 AVITA MEDICAL LIMITED (ABN 989 008 624 961) AND THE BANK OF NEW YORK MELLON As Depositary AND OWNERS AND HOLDERS OF AMERICAN DEPOSITARY SHARES Deposit Agreement , … $0.45. Our products provide innovative treatment solutions derived from the regenerative properties of a patient’s own skin. exhibit 1.1 . Our products provide innovative treatment solutions derived from the regenerative properties of a patient’s own skin. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus.

AVITA Medical is a publicly listed, global regenerative medicine company that provides a novel approach to skin regeneration. 0.12 (36.36%) DATA AS OF Jun 26, 2020. No use of any AVITA trademark, trade name, or trade dress in this site may be made without the prior written authorization of AVITA, except to identify the product or services of the company. View the AVMXF U.S. Securities and Exchange Commission reporting information. SEC Filings No use of any AVITA trademark, trade name, or trade dress in this site may be made without the prior written authorization of AVITA, except to identify the product or services of the company.

The shares of AVITA Medical Limited are traded on the Australian Stock Exchange (ASX) under the symbol “AVH” and on NASDAQ under the symbol "RCEL". Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to AVITA, its subsidiaries or affiliates. Avita Medical Ltd. all SEC filings breakout by MarketWatch.